Cargando…

Does early orchidopexy reduce risk of testicular cancer?

Detalles Bibliográficos
Autores principales:	Banerji, John S., Singh, J. Chandra
Formato:	Texto
Lenguaje:	English
Publicado:	Medknow Publications 2008
Materias:	Uroscan
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2684366/ https://www.ncbi.nlm.nih.gov/pubmed/19468490

Ejemplares similares

Does dutasteride reduce perioperative blood loss and postoperative complications after transurethral resection of the prostate?
por: Shanmugasundaram, R., et al.
Publicado: (2007)

Antibiotic prophylaxis in vesicoureteral reflux: A paradigm shift
por: Banerji, J. S., et al.
Publicado: (2009)

Approach to chemotherapy for high-risk, stage 1, non-seminomatous, germ cell testicular tumors
por: Anand, Madhur
Publicado: (2021)

Prostate cancer treatment does not increase the risk of cardiovascular events
por: Khochikar, Makarand V.
Publicado: (2007)

Renal and testicular involvement in COVID-19 patients – implication for the urologist
por: Pandey, Abhisek
Publicado: (2020)

Nitrous oxide during anesthesia for laparoscopic donor nephrectomy: Does it matter?
por: Singh, Pratipal, et al.
Publicado: (2008)

Temsirolimus, interferon alfa or both in advanced renal-cell carcinoma: One plus one does not always equal two
por: Grover, S., et al.
Publicado: (2007)

Stress urinary incontinence: Sling or colposuspension?
por: Mukha, Rajiv Paul, et al.
Publicado: (2007)

The current role of Active Surveillance in early prostate cancer
por: Shrinivas, R. P., et al.
Publicado: (2009)

Ureteroilleal anastomosis in orthotopic ileal neobladders: Does technique matter?
por: Gupta, Parag, et al.
Publicado: (2008)

Does tamsulosin facilitate expulsion of distal ureteric calculus following lithotripsy?
por: Gupta, Gaurav, et al.
Publicado: (2008)

Can early salvage radiotherapy replace adjuvant radiotherapy as the new standard of care for high-risk postradical prostatectomy patients?
por: Pandey, Abhishek
Publicado: (2021)

Does antenatal pelvic floor muscle training prevent stress urinary incontinence in primi-gravidae?
por: Gupta, Gaurav, et al.
Publicado: (2009)

Does treatment rate impact the efficacy of extracorporeal shock wave lithotripsy for kidney or ureteral stones?
por: Muruganandham, K., et al.
Publicado: (2007)

Endocrine treatment in advanced prostate cancer: When to start?
por: Choudhrie, A. V., et al.
Publicado: (2009)

The SMART trial; does it make us wiser in choosing between sirolimus in preference to cyclosporine – A postrenal transplant?
por: Mishra, Ankit
Publicado: (2021)

Rezvilutamide for metastatic castration-sensitive prostate cancer: CHART trial
por: Singh, Kirti
Publicado: (2023)

Triple therapy for metastatic castration sensitive prostate cancer: PEACE-1 trial
por: Singh, Kirti
Publicado: (2022)

Defining the role of antioxidants in the prevention of prostate cancer
por: Pathak, Hemant R., et al.
Publicado: (2009)

Docetaxel, abiraterone, enzalutamide, apalutamide in patients with metastatic hormone-sensitive prostate cancer
por: Talwar, Harkirat Singh
Publicado: (2021)

The effect of intravesical instillation of antifibrinolytic agents on bacillus Calmette-Guerin treatment of superficial bladder cancer: A pilot study
por: Vasudeva, Pawan, et al.
Publicado: (2008)

LATITUDE: A landmark trial for high-risk metastatic castration-sensitive prostate cancer: Final overall survival analysis
por: Kumar, Gautam
Publicado: (2020)

Comparing outcomes between neoadjuvant hormonal therapy followed by prostatectomy versus upfront prostatectomy in high-risk prostate cancer: The road ahead
por: Bhargava, Priyank
Publicado: (2023)

Follow-up after pyeloplasty: How long?
por: Nirmal, T. J., et al.
Publicado: (2008)

Alfuzosin for chronic pelvic pain syndrome: Another placebo?
por: Nirmal, T. J., et al.
Publicado: (2009)

Botulinum toxin in high-risk BPH patients in retention
por: Reddy, Sreedhar, et al.
Publicado: (2008)

Management of multiple/staghorn kidney stones: Open surgery versus PCNL (with or without ESWL)
por: Agrawal, Madhy S., et al.
Publicado: (2009)

Risk factors for persistent stress urinary incontinence after mid-urethral procedures
por: Chawla, Arun, et al.
Publicado: (2008)

PROpel trial: Are PARP inhibitors ready to become the first-line treatment for mCRPC?
por: Gaur, Abhay Singh
Publicado: (2022)

Checkmate 274 trial: Is Nivolumab the new standard in adjuvant setting for high-risk muscle invasive urothelial carcinoma?
por: Kumar, Naveen
Publicado: (2021)

Can tomato juice be used for prophylaxis in recurrent stone formers?
por: Agrawal, Madhu S., et al.
Publicado: (2009)

A comparison of traditional anterior colporrhaphy, polypropylene mesh and porcine dermis in cystocele repair
por: Singh, Pratipal, et al.
Publicado: (2007)

Intraprostatic injection of botulinum toxin A: A promising treatment for patients with benign prostatic hyperplasia
por: Agrawal, S. K., et al.
Publicado: (2009)

Safety and efficacy of active surveillance in patients with localized prostate cancer
por: Mavuduru, Ravimohan, et al.
Publicado: (2008)

Relugolix – The novel oral androgen deprivation therapy for prostate cancer
por: Jena, Rahul
Publicado: (2020)

Is incidence of prostate cancer higher in patients with end stage renal disease?
por: Khochikar, Makarand V.
Publicado: (2007)

T1 bladder cancer on restaging transurethral resection should be treated with immediate cystectomy
por: Gautam, Gagan, et al.
Publicado: (2007)

Intravesical real-time imaging and staging of bladder cancer: Use of optical coherence tomography
por: Sengottayan, Vengatesh K., et al.
Publicado: (2008)

Survival following primary androgen deprivation therapy among men with localized prostate cancer
por: Vasudeva, Pawan, et al.
Publicado: (2008)

Multiparametric magnetic resonance imaging-targeted biopsies in the detection of clinically significant prostate cancer
por: Charalampos, Fragkoulis
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nbcsk9498il060h31casel0gd7